Evangelina Delgado-González

ORCID: 0000-0003-2605-4632
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid Disorders and Treatments
  • Cancer, Stress, Anesthesia, and Immune Response
  • Cancer, Hypoxia, and Metabolism
  • Neuroblastoma Research and Treatments
  • Eicosanoids and Hypertension Pharmacology
  • Neonatal Health and Biochemistry
  • Hormonal and reproductive studies
  • Diet, Metabolism, and Disease
  • Photodynamic Therapy Research Studies
  • Growth Hormone and Insulin-like Growth Factors
  • Breast Cancer Treatment Studies
  • Inflammatory mediators and NSAID effects
  • Thyroid Cancer Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Bioactive Compounds and Antitumor Agents
  • Cancer Immunotherapy and Biomarkers
  • Heme Oxygenase-1 and Carbon Monoxide
  • Neurogenesis and neuroplasticity mechanisms
  • Nanoplatforms for cancer theranostics
  • Ultrasound and Hyperthermia Applications
  • Pancreatic function and diabetes
  • Veterinary Oncology Research
  • Hydrogen's biological and therapeutic effects
  • Antioxidant Activity and Oxidative Stress
  • Neuroendocrine regulation and behavior

Universidad Nacional Autónoma de México
2016-2025

Instituto Mexicano de Oftalmología IAP
2012-2019

Prostate cancer cells are responsive to adrenergic and thyroid stimuli. It is well established that β-adrenergic activation (protein kinase A [PKA]/cAMP response element binding protein [CREB]) promotes progression, but the role of hormones poorly understood. We analyzed effects stimulation (isoproterenol [ISO]) and/or hormone on neuroendocrine (NE) differentiation cell invasion, using in vivo (LNCaP tumor) vitro models DU145 human cells). Nude mice were inoculated with LNCaP treated for 6...

10.2119/molmed.2015.00047 article EN cc-by Molecular Medicine 2016-01-01

Cancer stem cells (CSCs) are described as a subpopulation of with capabilities self-renewal, chemoresistance, and invasiveness. CSCs reside in tumor niches can be studied vitro through their enrichment spheroids (Stem). Molecular iodine (I2) induces apoptosis differentiation various cancer cells. I2 activate peroxisome proliferator-activated receptors type gamma (PPARγ), its pathways associated oxidant/antioxidant capacity. This work aimed to compare the effect supplementation progenitor CSC...

10.3390/ijms26094020 article EN International Journal of Molecular Sciences 2025-04-24

Mammary cancer has a high incidence in canines and is an excellent model of spontaneous carcinogenesis. Molecular iodine (I2) exerts antineoplastic effects on different cells activating re-differentiation pathways. In co-administration with anthracyclines, I2 impairs chemoresistance installation prevents the severity side generated by these drugs. This study random double-blind protocol that analyzes impact (10 mg/day) two administration schemes Doxorubicin (DOX; 30 mg/m2) 27 canine patients...

10.1186/s12917-018-1411-6 article EN cc-by BMC Veterinary Research 2018-03-12

The immune system is a crucial component in cancer progression or regression. Molecular iodine (I2) exerts significant antineoplastic effects, acting as differentiation inductor and modulator, but its effects antitumor response are not elucidated. present work analyzed the effect of I2 human breast cell lines with low (MCF-7) high (MDA-MB231) metastatic potential under both vitro (cell proliferation invasion assay) vivo (xenografts athymic nude mice) conditions. In analysis showed that 200...

10.1186/s12885-019-5437-3 article EN cc-by BMC Cancer 2019-03-22

This study analyzes an oral supplement of molecular iodine (I2), alone and in combination with the neoadjuvant therapy 5-fluorouracil/epirubicin/cyclophosphamide or taxotere/epirubicin (FEC/TE) women Early (stage II) Advanced III) breast cancer. In group, 30 were treated I2 (5 mg/day) placebo (colored water) for 7–35 days before surgery. For patients received placebo, along FEC/TE treatment. After surgery, all + 170 days. supplementation showed a significant attenuation side effects absence...

10.3390/nu11071623 article EN Nutrients 2019-07-17

Neuroblastoma (Nb), the most common extracranial tumor in children, exhibited remarkable phenotypic diversity and heterogeneous clinical behavior. Tumors with MYCN overexpression have a worse prognosis. promotes progression by inducing cell proliferation, de-differentiation, dysregulated mitochondrial metabolism. Cyclophosphamide (CFF) at minimum effective oral doses (metronomic therapy) exerts beneficial actions on chemoresistant cancers. Molecular iodine (I2) coadministration all-trans...

10.3390/ijms22168936 article EN International Journal of Molecular Sciences 2021-08-19

This study analyzes oral supplement of molecular iodine (I2) alone and in combination with the neoadjuvant therapy 5-fluorouracil/epirubicin/cyclophosphamide or taxotere/epirubicin (FEC/TE) women Early (stage II) Advanced III) breast cancer. In group, 30 were treated I2 (5 mg/day) placebo (colored water) for 7–35 days before surgery. For patients received along FEC/TE treatment. After surgery, all + 170 days. supplementation showed a significant attenuation side effects absence...

10.20944/preprints201907.0152.v1 preprint EN 2019-07-11

Molecular iodine (I2) induces apoptotic, antiangiogenic, and antiproliferative effects in breast cancer cells. Little is known about its on the tumor immune microenvironment. We studied effect of oral (5 mg/day) I2 supplementation alone or together with conventional chemotherapy (Cht+I2) component tumors from a previously published pilot study conducted Mexico. RNA-seq, Cht+I2 samples showed significant increases expression Th1 Th17 pathways. Tumor composition determined by deconvolution...

10.3390/biom11101501 article EN cc-by Biomolecules 2021-10-12

Pancreatitis has been implicated in the development and progression of type 2 diabetes cancer. The pancreas uptakes molecular iodine (I2), which anti-inflammatory antioxidant effects. present work analyzes whether oral I2 supplementation prevents pancreatic alterations promoted by low doses streptozotocin (STZ). CD1 mice (12 weeks old) were divided into following groups: control; STZ (20 mg/kg/day, i.p. for five days); (0.2 mg/Kg/day drinking water 15 combined (STZ + I2). Inflammation...

10.3390/nu14030715 article EN Nutrients 2022-02-08

Neuroblastoma (NB) is the most common solid childhood tumor, and all-trans retinoic acid (ATRA) used as a treatment to decrease minimal residual disease. Molecular iodine (I 2 ) induces differentiation and/or apoptosis in several neoplastic cells through activation of PPARγ nuclear receptors. Here, we analyzed whether coadministration I ATRA increases efficacy NB treatment. ATRA-sensitive (SH-SY5Y), partially-sensitive (SK-N-BE(2)), non-sensitive (SK-N-AS) were analyze effect vitro...

10.1530/erc-20-0354 article EN Endocrine Related Cancer 2020-10-01

Pancreatic alterations such as inflammation and insulin resistance accompany hypothyroidism. Molecular iodine (I2) exerts antioxidant differentiation actions in several tissues, the pancreas is an iodine-uptake tissue. We analyzed effect of two oral I2 doses on pancreatic disorders a model hypothyroidism for 30 days. Adult female rabbits were divided into following groups: control, moderate dose (0.2 mg/kg, M-I2), high (2.0 H-I2), methimazole (MMI; 10 mg/kg), MMI + M-I2,, H-I2. Moderate or...

10.3390/ijms241914903 article EN International Journal of Molecular Sciences 2023-10-05

Molecular iodine (I2) induces apoptotic, antiangiogenic, and antiproliferative effects in breast cancer cells. Little is known about its on the tumor immune microenvironment. We studied effect of oral (5 mg/day) I2 supplementation alone or together with conventional chemotherapy (Cht+I2) im-mune component tumors from a previously published pilot study conducted Mexico. RNA-seq, Cht+I2 samples showed significant increases expression Th1 Th17 pathways. Tumor composition determined by...

10.20944/preprints202109.0170.v1 preprint EN 2021-09-09

Thyronines are essential for the development of male reproductive system, including prostate gland. Metabolically active 3,5,3' triiodothyronine (T(3)) is generated mainly by extrathyroidal, enzymatic 5'deiodination prohormone thyroxine (T(4)), which catalyzed deiodinases type 1 (D1) and 2 (D2). Prostate D1 activity highly expressed during puberty declines with age, but continuous, long-term sexual prevents this reduction. The aims study were to characterize changes in prostatic response...

10.1095/biolreprod.110.086116 article EN Biology of Reproduction 2010-09-02

Thyroxine (T4) promotes cell proliferation and tumor growth in prostate cancer models, but it is unknown if the increase triiodothyronine (T3)/T4 ratio could attenuate development. We assessed T3 effects on thyroid response, histology, proliferation, apoptosis of wild-type (WT) TRAMP (transgenic adenocarcinoma mouse prostate) mice. Physiological doses were administered drinking water (2.5, 5 15 µg/100 g body weight) for 6 weeks. None modified weight or serum levels testosterone, all them...

10.1530/joe-20-0310 article EN Journal of Endocrinology 2020-09-29

Pancreatic alterations like inflammation and insulin resistance accompany hypothyroidism. Molecular iodine (I2) exerts antioxidant differentiation actions in several tissues, the pancreas is an iodine-uptake tissue. We analyzed effect of two oral I2 doses on pancreatic disorders a model hypothyroidism for 30 days. Adult female rabbits were divided into following groups: control, moderate dose (0.2 mg/kg, M-I2), high (2.0 H-I2), methimazole (MMI; 10 mg/kg), MMI+M-I2, MMI+H-I2. Moderate or...

10.20944/preprints202308.0639.v1 preprint EN 2023-08-08

Metronomic chemotherapy with cyclophosphamide (Cpp) has shown promising results in cancer protocols. These lower and prolonged doses have antiangiogenic, pro-cytotoxic, moderate secondary effects. Molecular iodine (I2) reduces the viability of cells and, chemotherapeutic agents, activates antitumoral immune response diminishes side The present work evaluates adjuvant oral I2 Cpp using a murine model mammary cancer. Female Sprague Dawley rats 7,12-dimethylbenzantracene-induced tumors received...

10.3390/ijms25168822 article EN International Journal of Molecular Sciences 2024-08-13

Abstract Neuroblastoma (NB) is one of childhood´s most common extra-cranial solid tumors, with 90 % the cases occurring in those <5 years age. NB highly heterogeneous, variable biological and clinical characteristics; it exhibits spontaneous or induced regression processes (low-risk NB) up to invasive capacities drug-resistance tumors (high-risk NB). High-risk overexpresses N-MYC gene associated invasion chemoresistance. On other hand, molecular iodine (I2) exerts antiproliferative...

10.1158/1538-7445.pediatric24-a057 article EN Cancer Research 2024-09-05

Pancreatitis and insulitis are known causes of type 2 diabetes mellitus, recently it has been shown that hypothyroidism can exacerbate these alterations. Molecular iodine (I2) exerts antioxidant, anti-inflammatory, anti-dyslipidemia effects in diverse tissues. The objective this study was to evaluate the effect oral supplement halogen induction prediabetic status a model pharmacological hypothyroidism. Adult virgin rabbits Chinchilla breed were divided into control (n = 6) hypothyroid...

10.1210/js.2019-sat-561 article EN cc-by-nc-nd Journal of the Endocrine Society 2019-04-01
Coming Soon ...